Kudo Rei

クドウレイ | Kudo Rei

Research field (1)： Tumor biology

Research theme for competitive and other funds (2)：

2024 - 2026 がんに対する新規核酸医薬療法の前臨床試験
2014 - 2016 The elucidation of the mechanism by which DYRK2 expression is regulated

Papers (18)：

Rei Kudo, Anton Safonov, Catherine Jones, Enrico Moiso, Jonathan R Dry, Hong Shao, Sharanya Nag, Edaise M da Silva, Selma Yeni Yildirim, Qing Li, et al. Long-term breast cancer response to CDK4/6 inhibition defined by TP53-mediated geroconversion. Cancer cell. 2024. 42. 11. 1983-1983
Rei Kudo, Anton Safonov, Catherine Jones, Enrico Moiso, Jonathan R Dry, Hong Shao, Sharanya Nag, Edaise M da Silva, Selma Yeni Yildirim, Qing Li, et al. Long-term breast cancer response to CDK4/6 inhibition defined by TP53-mediated geroconversion. Cancer cell. 2024
Qing Li, Baishan Jiang, Jiaye Guo, Hong Shao, Isabella S Del Priore, Qing Chang, Rei Kudo, Zhiqiang Li, Pedram Razavi, Bo Liu, et al. INK4 Tumor Suppressor Proteins Mediate Resistance to CDK4/6 Kinase Inhibitors. Cancer discovery. 2022. 12. 2. 356-371
Eijiro Nagasaki, Rei Kudo, Miho Tamura, Kazumi Hayashi, Tadashi Uwagawa, Yoshikazu Kijima, Hiroko Nogi, Hiroshi Takeyama, Masafumi Suzuki, Masako Nishikawa, et al. Long-term outcomes of oligometastatic breast cancer patients treated with curative intent: an updated report. Breast cancer (Tokyo, Japan). 2021. 28. 5. 1051-1061
Atsushi Fushimi, Rei Kudo, Hiroshi Takeyama. Do Decreased Breast Microcalcifications After Neoadjuvant Chemotherapy Predict Pathologic Complete Response?. Clinical breast cancer. 2020. 20. 1. e82-e88

ｍore...

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page